Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The Journal of Invasive Cardiology
|
March 24, 2000
Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier
M Desai, C L Lucore
Circulation
|
March 1, 1988
Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications
C L Lucore, B E Sobel
Circulation
|
June 1, 1989
Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration
C L Lucore, S Fujii, B E Sobel
The American Journal of Medicine
|
May 1, 1994
Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response
S R Deitcher, C L Lucore, P R Eisenberg
The Journal of Infection
|
March 1, 1984
An experimental model for pyogenic liver abscess
M I McDonald, C L Lucore, D T Durack
Journal of Vascular Surgery
|
May 1, 1994
Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease
J M Reilly, G A Sicard, C L Lucore
Liver
|
June 1, 1986
Experimental anaerobic liver abscess: observations on treatment
C L Lucore, M I McDonald, M Wharton, et al.
Circulation
|
December 1, 1992
Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo
S Fujii, H Sawa, J E Saffitz, et al.
Circulation
|
April 1, 1988
Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation
C L Lucore, E T Fry, D A Nachowiak, et al.
The Journal of Invasive Cardiology
|
April 4, 2000
Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital
C L Lucore, G J Mishkel, R W Ligon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The Journal of Invasive Cardiology
|
March 24, 2000
Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier
M Desai, C L Lucore
Circulation
|
March 1, 1988
Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications
C L Lucore, B E Sobel
Circulation
|
June 1, 1989
Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration
C L Lucore, S Fujii, B E Sobel
The American Journal of Medicine
|
May 1, 1994
Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response
S R Deitcher, C L Lucore, P R Eisenberg
The Journal of Infection
|
March 1, 1984
An experimental model for pyogenic liver abscess
M I McDonald, C L Lucore, D T Durack
Journal of Vascular Surgery
|
May 1, 1994
Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease
J M Reilly, G A Sicard, C L Lucore
Liver
|
June 1, 1986
Experimental anaerobic liver abscess: observations on treatment
C L Lucore, M I McDonald, M Wharton, et al.
Circulation
|
December 1, 1992
Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo
S Fujii, H Sawa, J E Saffitz, et al.
Circulation
|
April 1, 1988
Biochemical determinants of clearance of tissue-type plasminogen activator from the circulation
C L Lucore, E T Fry, D A Nachowiak, et al.
The Journal of Invasive Cardiology
|
April 4, 2000
Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital
C L Lucore, G J Mishkel, R W Ligon, et al.
Page
of 2